MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations

Blood

Volumn 120, Issue 13, 2012, Pages 2719-2722

  Antony Debré, Iléana ^a,b,c   Bluteau, Dominique ^a,b,c   Itzykson, Raphael ^a,b,c   Baccini, Veŕonique ^a   Renneville, Aline ^d   Boehlen, Françoise ^e   Morabito, Margot ^a,b,c   Droin, Nathalie ^a,b,c   Deswarte, Caroline ^a,f   Chang, Yunhua ^a,b,c   Leverger, Guy ^a,f,g   Solary, Eric ^a,b,c   Vainchenker, William ^a,b,c   Favier, Rémi ^a,g   Raslova, Hana ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f SORBONNE UNIVERSITÉ   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN IIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FLI1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME NUMBER; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; FAMILIAL PLATELET DISORDER; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; JACOBSEN SYNDROME; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE DISORDER; THROMBOCYTOPENIA;

EID: 84866878349     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-422352     Document Type: Article

References (11)

1. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23(2):166-175. (Pubitemid 29455388)
2. Kuo MC, Liang DC, Huang CF, et al. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation. Leukemia. 2009;23(8):1426-1431.
3. Bacher U, Haferlach T, Schnittger S, Kreipe H, Kroger N. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia. Br J Haematol. 2011;153(2):149-167.
4. Gelsi-Boyer V, Trouplin V, Adelaide J, et al. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer. 2008;8:299.
5. Lordier L, Bluteau D, Jalil A, et al. RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun. 2012;3:717.
6. Raslova H, Komura E, Le Couedic JP, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest. 2004;114(1): 77-84. (Pubitemid 39071646)
7. Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet. 2011;43(8):735-737.
8. Tijssen MR, Cvejic A, Joshi A, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011; 20(5):597-609.
9. Huang H, Yu M, Akie TE, et al. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol Cell Biol. 2009;29(15):4103-4115.
10. Noris P, Perrotta S, Seri M, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood. 2011;117(24):6673-6680.
11. Yu M, Mazor T, Huang H, et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell. 2012;45(3):330-343.